Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
Henry Sutanto, Dobromir Dobrev, Jordi Heijman
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8994-8994
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential
Thomas G. Martin, Miranda A. Juarros, Leslie A. Leinwand
Nature Reviews Cardiology (2023) Vol. 20, Iss. 5, pp. 347-363
Open Access | Times Cited: 75
Recent Advances in Antiarrhythmic Drug Therapy
Arnela Saljic, Jordi Heijman, Dobromir Dobrev
Drugs (2023) Vol. 83, Iss. 13, pp. 1147-1160
Open Access | Times Cited: 31
Role of the renin–angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products
Jinit K. Mehta, Ginpreet Kaur, Harpal S. Buttar, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 22
Emerging Antiarrhythmic Drugs for Atrial Fibrillation
Arnela Saljic, Jordi Heijman, Dobromir Dobrev
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4096-4096
Open Access | Times Cited: 36
Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
Andryanto Sutanto, Citrawati Dyah Kencono Wungu, Hendri Susilo, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3568-3568
Open Access | Times Cited: 37
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Nor Hidayah Mustafa, Juriyati Jalil, Satirah Zainalabidin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Sacubitril-Valsartan in Cancer Therapy-Induced Heart Failure: A Systematic Review and Meta-Analysis of Functional and Hemodynamic Parameters
RAMON HUNTERMANN, Caroline O Fischer-Bacca, Magda Alves, et al.
Current Problems in Cardiology (2025), pp. 102987-102987
Closed Access
Real-world, in-clinic challenges and opportunities in the management of heart failure patients with dyslipidaemia: comprehensive experiences by healthcare professionals
Kunal Khobragade, Neeraj Kumar
International Journal of Research in Medical Sciences (2025) Vol. 13, Iss. 2, pp. 702-706
Open Access
A short history of the atrial NLRP3 inflammasome and its distinct role in atrial fibrillation
Theresa Poppenborg, Arnela Saljic, Florian Bruns, et al.
Journal of Molecular and Cellular Cardiology (2025) Vol. 202, pp. 13-23
Open Access
Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?
Pablo Díez‐Villanueva, César Jiménez-Méndez, Ángel Pérez, et al.
Cardiology (2023) Vol. 148, Iss. 3, pp. 195-206
Open Access | Times Cited: 7
Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure
Velia Cassano, Giuseppe Armentaro, Marcello Magurno, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
Michele Correale, Michele Magnesa, Pietro Mazzeo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 1086-1086
Open Access | Times Cited: 6
Possible role of LCZ696 in atherosclerosis: new inroads and perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 8, pp. 1895-1908
Closed Access | Times Cited: 6
Sacubitril/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study
Mauro Acquaro, Laura Scelsi, Beatrice Pasotti, et al.
Vascular Pharmacology (2023) Vol. 152, pp. 107196-107196
Closed Access | Times Cited: 5
Arterial Hypertension in Aortic Valve Stenosis: A Critical Update
Christian Basile, Ilaria Fucile, Maria Lembo, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 23, pp. 5553-5553
Open Access | Times Cited: 12
Unraveling the Differentially Articulated Axes of the Century-Old Renin–Angiotensin–Aldosterone System: Potential Therapeutic Implications
Pitchai Balakumar, Shaminder Handa, Ali Alqahtani, et al.
Cardiovascular Toxicology (2022) Vol. 22, Iss. 3, pp. 246-253
Closed Access | Times Cited: 8
The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022
Xia Xu, Yumeng Li, Shuqing Shi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Effect of sacubitril/valsartan on the occurrence of cardiac arrhythmias and the risk of sudden cardiac death in heart failure: A meta-analysis of randomized controlled trials
Xuehui Liu, Guanling Wang, Qiang Xu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Empagliflozin combined with sacubitril/valsartan in hypertensive patients with heart failure: a retrospective study of efficacy and effect on blood pressure variability and cardiac function
Yongxian Ma, Wei Li, Yunfeng Liu, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 7, pp. 3036-3045
Open Access | Times Cited: 1
Renin–angiotensin–aldosterone system and blood pressure regulation
Gino Seravalle, Guıdo Grassı
Elsevier eBooks (2023), pp. 63-75
Closed Access | Times Cited: 4
Angiotensin Receptor‐Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure
Andreas A. Boehmer, Tim Schubert, M Rothe, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
The Evidence for Sparsentan-Mediated Inhibition of INa and IK(erg): Possibly Unlinked to Its Antagonism of Angiotensin II or Endothelin Type a Receptor
Tzu-Hsien Chuang, Hsin‐Yen Cho, Sheng‐Nan Wu
Biomedicines (2021) Vol. 10, Iss. 1, pp. 86-86
Open Access | Times Cited: 10
A narrative review on sacubitril/valsartan and ventricular arrhythmias
Zhaoyang Wei, Meiwei Zhang, Qian Zhang, et al.
Medicine (2022) Vol. 101, Iss. 27, pp. e29456-e29456
Open Access | Times Cited: 5
Sudden cardiac death prevention in the era of novel heart failure medications
I. Koev, Merav Yarkoni, David Luria, et al.
American Heart Journal Plus Cardiology Research and Practice (2023) Vol. 27, pp. 100281-100281
Open Access | Times Cited: 2
PERSPECTIVAS E DESAFIOS DAS DROGAS ANTIARRÍTMICAS: MITIGANDO O RISCO DE PROARRITMIA
Ana Paula Porto Campos e Campos, Bárbara Aparecida de Souza e Souza, Diego Farias Costa, et al.
EPITAYA eBooks (2024), pp. 13-40
Open Access
Page 1 - Next Page

Scroll to top